Literature DB >> 16602021

Homocysteine, folate, lipid profile and MTHFR genotype and disability in children with myelomeningocele.

Claudia Rendeli1, Emanuele Ausili, Mario Castorina, Daniela Antuzzi, Fabrizia Tabacco, Massimo Caldarelli.   

Abstract

STUDY
DESIGN: We performed a cross-sectional study in myelomeningocele children.
OBJECTIVE: To investigate plasma total homocysteine, folate, lipid profile, 5,10- metylenetetrahydrofolate reductase genotype (MTHFR) and disability.
MATERIALS AND METHODS: Sixty patients aged between 2 and 14 years with myelomeningocele (18 ambulatory and 42 non-ambulatory) and 150 healthy children of same age, are investigated for lipid profile, homocysteine concentration and for the determination of MTHFR genotype.
RESULTS: Plasma homocysteine concentrations were significantly higher in myelomeningocele children than in the control group. In myelomeningocele female group, there were higher levels of total cholesterol and very-low-density lipoprotein cholesterol with respect to the control group. Myelomeningocele children walking with tutorial aid showed triglyceride levels significantly lower than those observed in myelomeningocele non-walking children.
CONCLUSION: Disability, insulin uptake, lipid, homocysteine, hormones plasma levels, and genetic factors such as allelic variants of MTHFR are possible for cardiovascular disease in myelomeningocele children. This study highlights the importance of a continuous surveillance of any changes in the lipid profile that should be corrected as soon as possible. Constant physical activity necessary to increase HDL levels should be planned in all susceptible children. Nonetheless, further investigations are necessary to identify new homocysteine susceptible genes for prevention of early atherosclerosis and consequent cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16602021     DOI: 10.1007/s00381-006-0056-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  43 in total

1.  Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study.

Authors:  S E Vollset; H Refsum; L M Irgens; B M Emblem; A Tverdal; H K Gjessing; A L Monsen; P M Ueland
Journal:  Am J Clin Nutr       Date:  2000-04       Impact factor: 7.045

2.  The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.

Authors:  H G Koch; P Nabel; R Junker; K Auberger; R Schobess; A Homberger; M Linnebank; U Nowak-Göttl
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

3.  Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study.

Authors:  L E Martínez de Villarreal; I Delgado-Enciso; R Valdéz-Leal; R Ortíz-López; A Rojas-Martínez; C Limón-Benavides; M A Sánchez-Peña; J Ancer-Rodríguez; H A Barrera-Saldaña; J Z Villarreal-Pérez
Journal:  Arch Med Res       Date:  2001 Jul-Aug       Impact factor: 2.235

Review 4.  Homocysteine and renal disease.

Authors:  C van Guldener; K Robinson
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

5.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.

Authors:  C Heller; R Schobess; K Kurnik; R Junker; G Günther; W Kreuz; U Nowak-Göttl
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

6.  Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.

Authors:  Kelly A Volcik; Gary M Shaw; Edward J Lammer; Huiping Zhu; Richard H Finnell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-03

7.  Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.

Authors:  V A Fonseca; S Mudaliar; B Schmidt; L M Fink; P A Kern; R R Henry
Journal:  Metabolism       Date:  1998-06       Impact factor: 8.694

8.  Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.

Authors:  C J Glueck; P Shaw; J E Lang; T Tracy; L Sieve-Smith; Y Wang
Journal:  Am J Cardiol       Date:  1995-01-15       Impact factor: 2.778

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  2 in total

1.  Fasting serum blood measures of bone and lipid metabolism in children with myelomeningocele for early detection of cardiovascular and bone fragility risk factors.

Authors:  Alexander Van Speybroeck; Nicole M Mueske; Steven D Mittelman; Richard K Kremer; Deirdre D Ryan; Tishya A L Wren
Journal:  J Spinal Cord Med       Date:  2015-12-14       Impact factor: 1.985

2.  A review of the potential for cardiometabolic dysfunction in youth with spina bifida and the role for physical activity and structured exercise.

Authors:  Kevin R Short; Dominic Frimberger
Journal:  Int J Pediatr       Date:  2012-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.